Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
暂无分享,去创建一个
T. Kishimoto | N. Nishimoto | T. Miyamae | M. Mori | S. Yokota | M. Tomiita | T. Imagawa | N. Iwata | Y. Aihara | T. Murata | S. Takei | H. Umebayashi | M. Miyoshi